Lucy’s healthcare professional: Nishti Udeh, Registered Dietitian and Founder of online nutrition consultancy clinic Nishti’s Choice. Formerly Lead Dietitian at an eating disorder unit.
.png){kind=icon}
Lucy faced challenges with feeding from the early stages of her life, including difficulties with the introduction of solid foods. Her food preferences were subsequently weighted towards ‘beige’ carbohydrate-rich food.
Despite dietary challenges, Lucy seemed to thrive during the 2020 Covid-19 ‘lockdown’, however, upon returning to school, changes in her behaviour, such as food refusal, sensory sensitivity, school aversion, fearfulness, and difficulties with eye contact, were observed.
These observations, along with concerns about her weight led to the diagnosis of the increasingly more frequently encountered combination of Autism Spectrum Disorder (ASD) and Avoidant Restrictive Food Intake Disorder (ARFID). Lucy was admitted to a general paediatric inpatient ward for 4 weeks, then once medically stable was transferred to an Eating Disorder Unit (EDU) for treatment with the nutritional objectives of:
During her admission on the general paediatric ward, she received a continuous enteral feeding regime. Despite efforts to meet her nutritional requirements with enteral feeding, there was no improvement in her weight, and Lucy was also treated for suspected refeeding syndrome. Lucy was initiated on PaediaSure Compact*, twice daily, via a nasogastric tube in accordance with MEED (Medical Emergencies in Eating Disorders) guideline recommendations. Lucy’s weight gain trajectory continued in line with MEED guidelines, increasing by 0.5-1 kg per week, steadily towards her target weight of 46 kg.
After 2 months, an open and negotiable approach was taken in introducing PaediaSure Compact into Lucy’s oral intake strategy. It’s crucial for children with ARFID and ASD to feel heard and employing negotiation tactics helped encourage Lucy to make these changes which resulted in her BMI steadily reaching the 13th centile.
Three months after admission, with coaching from her dietitian, Nishti, and the multidisciplinary (MDT) team, Lucy gradually began to consume PaediaSure Compact three times daily. At this time, she exhibited great progress as her weight had improved and stabilised.
To encourage Lucy to consider oral intake of solid food, negotiation took place to substitute her enteral feed for her favourite snack, however, shortly after stopping her enteral feeds, she began to lose weight again. Lucy chose to revert to PaediaSure Compact as her preferred way to increase her caloric intake.
Six months after being admitted to the EDU, Lucy was discharged at her target weight of 46kg and a BMI centile of 17.65. This was an increase on her original weight of 44-45 kg before her diagnosis. She was eating more food and maintained consumption of PaediaSure Compact twice daily. She was able to eat breakfast and a sandwich for lunch, as well as snacks, though she struggled with hot meals.
Learn more about Lucas and his health challenges.
Learn more about Rebecca and her health challenges.
Eager elephants strawberry smoothie
Serves 1
Footnotes:
*PaediaSure Compact is for ages 1-10 years or children weighing 8-30kg. The use of PaediaSure Compact outside of these ranges is under the supervision of the healthcare professional and their clinical judgement.
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.
Stay Connected